Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target [Yahoo! Finance]
Immuron Limited - American Depositary Shares (IMRN)
US:NASDAQ Investor Relations:
immuron.com/investor-centre/business-overview
Company Research
Source: Yahoo! Finance
Limited (Nasdaq:IMRN), maintaining its Buy-Extended rating and 12-month price target of $3.50 following the Company's release of first-half fiscal year 2026 operating results. The Flash Report notes that Immuron reported global revenue of AUD$4.2 million for the six months ended December 31, 2025, representing a 5% increase compared to the prior-year period. Sales growth was driven primarily by continued demand for Travelan ® , the Company's over-the-counter immune supplement, particularly in Australia and the United States. By geography, Australian revenue increased 13% year-over-year to AUD$3.3 million, while U.S. revenue rose 17% to AUD$0.9 million. Canadian revenue declined during the period, reflecting distributor-level inventory dynamics. Emerging Growth Research attributes overall performance to a combination of digital and in-store marketing initiatives and increased international travel activity. The report also highlights the December 2025 launch of ProIBS ® , Immuron'
Show less
Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMRN alerts
High impacting Immuron Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMRN
News
- Immuron Reports Continued Sales Growth [Yahoo! Finance]Yahoo! Finance
- Immuron Reports Continued Sales GrowthGlobeNewswire
- Immuron (IMRN) Struggles After Announcing Trial Results [Yahoo! Finance]Yahoo! Finance
- Immuron New U.S. Department of Defense Award & Clinical Trial UpdateGlobeNewswire
- Immuron IMM-529 IND approved by FDAGlobeNewswire
IMRN
Sec Filings
- 1/23/26 - Form 6-K
- 1/20/26 - Form 6-K
- 1/14/26 - Form 6-K
- IMRN's page on the SEC website